tiprankstipranks
Advertisement
Advertisement

VSTM Stock Latest News

Verastem up 11% at $4.00 after announcing FDA Fast Track designation for VS-7375
The FlyVerastem up 11% at $4.00 after announcing FDA Fast Track designation for VS-7375
16h ago
VSTM
Verastem announces FDA Fast Track designation for VS-7375
PremiumThe Fly
Verastem announces FDA Fast Track designation for VS-7375
16h ago
VSTM
Verastem Shareholders Back Board, Executive Pay and Plans
PremiumCompany Announcements
Verastem Shareholders Back Board, Executive Pay and Plans
9d ago
8K
VSTM
Verastem appoints Michael Bailey to board of directors
PremiumThe Fly
Verastem appoints Michael Bailey to board of directors
9d ago
VSTM
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
11d ago
WVE
REAX
Verastem price target lowered to $14 from $16 at Mizuho
PremiumThe FlyVerastem price target lowered to $14 from $16 at Mizuho
21d ago
VSTM
Verastem Inc Earnings Call Highlights Growth And Risk
Premium
Company Announcements
Verastem Inc Earnings Call Highlights Growth And Risk
26d ago
VSTM
Verastem price target lowered to $18 from $19 at BTIG
Premium
The Fly
Verastem price target lowered to $18 from $19 at BTIG
27d ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
PremiumThe Fly
Verastem price target raised to $18 from $16 at Alliance Global
27d ago
VSTM
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
PremiumThe Fly
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
28d ago
VSTM
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
PremiumCompany Announcements
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
28d ago
8K
VSTM
VSTM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VSTM Upcoming Earnings Report: What to Expect?
1M ago
VSTM
Verastem announces launch of Reimagine Recurrent LGSOC campaign
PremiumThe FlyVerastem announces launch of Reimagine Recurrent LGSOC campaign
1M ago
VSTM
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
Premium
Ratings
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
1M ago
VSTM
3 Best Stocks to Buy Today, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, According to Top Analysts
2M ago
BBOT
VSTM
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
PremiumRatings
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
2M ago
VSTM
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
PremiumThe Fly
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
2M ago
VSTM
Verastem assumed with a Buy at Jefferies
PremiumThe Fly
Verastem assumed with a Buy at Jefferies
2M ago
VSTM
Verastem management to meet with Cantor
PremiumThe Fly
Verastem management to meet with Cantor
2M ago
VSTM
Verastem assumed with a Buy at BTIG
PremiumThe FlyVerastem assumed with a Buy at BTIG
3M ago
VSTM
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
Premium
Ratings
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
3M ago
VSTM
Verastem Earnings Call: Early Momentum, Long Runway Risks
Premium
Company Announcements
Verastem Earnings Call: Early Momentum, Long Runway Risks
3M ago
VSTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >